| Value | ₹281.4 Cr |
|---|---|
| Execution period | Up to 8 years |
NSE filing, NSE: MOTHERSON. Summary written from the filing by ALFA Finder's alert engine.
Samvardhana Motherson International Ltd: key numbers
- Share price
- ₹160.33
- Market cap
- ₹1,69,219 Cr
- Revenue (annual)
- ₹1,26,104 Cr
- Net profit (annual)
- ₹3,860 Cr
- P/E (TTM)
- 38.6×Sector 30.9×
- Promoter holding
- 48.60%+0.00% QoQ
- FII holding
- 13.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Samvardhana Motherson International Ltd
All →Samvardhana Motherson International Legal & Regulatory
Motherson paid a ₹0.36 Crore FEMA compounding fee to RBI for unregistered 2007 bonus shares held by foreign shareholders. No material financial or operational impact.
- Value
- ₹0.36 Cr
Samvardhana Motherson International Legal & Regulatory
Samvardhana Motherson's US subsidiary received a Notice of Penalty Rescission, revoking a USD 19,500 penalty from the New York State Workers' Compensation Board after its appeal. The company is updating its 14 October 2026 disclosure.
- Value
- ₹0.19 Cr
Samvardhana Motherson International Acquisition
NCLT Mumbai approved amalgamation of three wholly-owned subsidiaries into Samvardhana Motherson International. No consideration as all entities are wholly-owned; no change in listed entity shareholding.
Samvardhana Motherson International Merger & Restructuring
The NCLT Mumbai Bench approved a composite scheme of arrangement involving four Motherson entities, including a demerger and amalgamations with wholly owned subsidiaries. The excerpt states no transaction value.
Samvardhana Motherson International Debt & Borrowing
Samvardhana Motherson filed its half-yearly statement of outstanding NCDs and CPs for April–September 2026. The filing covers four active debt tranches with stated maturity and coupon details.
Samvardhana Motherson International Other Announcement
Samvardhana Motherson International Limited has intimated details of its Compliance Officer and RTA pursuant to SEBI Listing Regulations, 2015 for the half-year ended September 30, 2026.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.